🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single-center, open-label, phase I clinical trial aimed to evalua...
Status
Unknown
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2021-08-01
Trial ID
NCT05507606
Treatments Being Tested
This randomized phase II trial studies how well erlotinib hydrochloride (Ta...
Status
Completed
Location
UC San Diego Moores Cancer Center
Start Date
2012-03-16
Trial ID
NCT01532089
Treatments Being Tested
This phase Ib trial finds the best dose and side effects of ensartinib and ...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2021-03-18
Trial ID
NCT04837716
Treatments Being Tested
Ovarian clear cell carcinoma (OCCC) is one of the rare subtypes of ovarian ...
Status
Completed
Location
Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology
Start Date
2021-04-07
Trial ID
NCT04735861
Treatments Being Tested
This study was a prospective, single-arm, single-center, phase II explorato...
Status
Unknown
Location
Hunan Cancer Hospital
Start Date
2022-08-01
Trial ID
NCT05530785
Treatments Being Tested
This randomized phase III trial studies carboplatin given together with pac...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2010-10-12
Trial ID
NCT01081262
This phase II trial studies the side effects of bevacizumab and anetumab ra...
Status
Active Not Recruiting
Location
UC Irvine Health/Chao Family Comprehensive Cancer Center
Start Date
2018-10-12
Trial ID
NCT03587311
Treatments Being Tested
This is a multicenter, multinational, double-blind, 1:1 randomized, paralle...
Status
Completed
Location
MedRadius
Start Date
2018-02-06
Trial ID
NCT03296163
Treatments Being Tested
In this randomized, double-blind, multicenter, phase III similarity study, ...
Status
Completed
Location
TOT
Start Date
2017-10-20
Trial ID
NCT05427305
Treatments Being Tested
To confirm the PK similarity of IBI305 and bevacizumab in healthy volunteer...
Status
Completed
Location
Jilin University First Hospital
Start Date
2017-03-09
Trial ID
NCT03083990
Treatments Being Tested